A Drug-Drug Interaction Study of FDL169 and FDL176 in Healthy Subjects
NCT03516331
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Cystic Fibrosis
Interventions
DRUG:
FDL176 & FDL169 coadministration
Sponsor
Flatley Discovery Lab LLC